Latuda Enters ‘Twilight’ Phase Pending Generic Competition

Lurasidone Launches Could Have Knock-On Effect On Caplyta Market

 
• By Chloe Kent

A swathe of generic lurasidone launches following the originator’s US patent expiry may trigger a shift in the antipsychotics space.

Silhouette of branches against twilight sunset
Analysts described Latuda as having entered a 'twilight' phase • Source: Shutterstock

More from Generics

More from Products